Skip to main content
. 2014 Mar 18;9(3):e90793. doi: 10.1371/journal.pone.0090793

Figure 3. DBDFT inhibits the growth of tumor in mice implanted with S180 and H22 cancer.

Figure 3

Mice were treated every day via tail vein with DBDFT and cisplatin for 10 consecutive days. Images of the subcutaneous tumors de rived from the S18 and H22 mice are shown. (a) S18 mice; (b) H22 mice (means±SD).